Skip to main content
logo
Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
13.20
0.00 (0.00%)
Oct 30, 2026, 9:54 AM EDT - Market open

Eloxx Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--6.36---
Revenue Growth
------
Gross Profit
--6.36---
Operating Income
-11.88-6.44-2.47-17.29-34.42-42.35
Net Income
-10.65-6-3.14-17.05-36.07-66.73
Earnings Per Share
-2.84-5.34-9.20-72.98-183.15-419.65
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
61.964.780.111.1319.2142.27
Total Debt
11.8312.8219.8716.9325.9217.18
Net Cash (Debt)
50.13-8.03-19.76-15.8-6.7125.09
Net Cash Growth
-----112.14%
Net Cash Per Share
13.38-7.15-57.82-67.60-34.08157.78

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-16.02-6.33-4.72-14.34-31.85-35
Capital Expenditures
-----0.07-0.09
Free Cash Flow
-16.02-6.33-4.72-14.34-31.91-35.09
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%---
Operating Margin
---38.81%---
Pretax Margin
---49.43%---
Profit Margin
---49.43%---
FCF Margin
---74.15%---

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--0---